Wendy Adams joined the Bay Area Lyme Foundation (BAL) in 2012. As a member of the science committee and Advisory Board, she provides strategic research advice and identifies, vets and manages our research opportunities, including the Lyme Disease Biobank. Her unique perspective and knowledge as a former Lyme patient—as well as her background in finance, strategy and business development for companies like Cowen, Genentech and Aviron—make her skill set uniquely valuable to BAL. Wendy has spent over 20 years in the biotechnology field and most recently served as Chief Business Officer at Full Spectrum Genetics, Inc., an antibody engineering company pursuing programs in immuno-oncology and autoimmune disease. Previously, she ran B2DC LLC, a business development consultancy to biotech clients in infectious and autoimmune disease, respiratory disease, oncology, drug delivery and neurology. Wendy holds an MBA from the Haas School of Business, University of California at Berkeley, where she also served on the faculty in Entrepreneurship, and an AB in Comparative Area Studies from Duke University.